GlaxoSmithKline
GSK
#209
Rank
โ‚ฌ84.11 B
Marketcap
41,67ย โ‚ฌ
Share price
-0.82%
Change (1 day)
31.70%
Change (1 year)

GlaxoSmithKline (GSK) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ70.75 Billion

According to GlaxoSmithKline's latest financial reports the company's total assets are โ‚ฌ70.75 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

GlaxoSmithKline - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ71.70 B5.45%
2023-12-31โ‚ฌ68.00 B0.24%
2022-12-31โ‚ฌ67.83 B-28.05%
2021-12-31โ‚ฌ94.28 B5.78%
2020-12-31โ‚ฌ89.13 B-4.45%
2019-12-31โ‚ฌ93.28 B44.79%
2018-12-31โ‚ฌ64.42 B1.45%
2017-12-31โ‚ฌ63.50 B-8.37%
2016-12-31โ‚ฌ69.30 B-4.32%
2015-12-31โ‚ฌ72.43 B39.2%
2014-12-31โ‚ฌ52.03 B3.52%
2013-12-31โ‚ฌ50.26 B-0.82%
2012-12-31โ‚ฌ50.68 B3.09%
2011-12-31โ‚ฌ49.16 B0.32%
2010-12-31โ‚ฌ49.01 B1.24%
2009-12-31โ‚ฌ48.41 B17.22%
2008-12-31โ‚ฌ41.29 B-2.19%
2007-12-31โ‚ฌ42.22 B11.35%
2006-12-31โ‚ฌ37.92 B-4.2%
2005-12-31โ‚ฌ39.58 B23.54%
2004-12-31โ‚ฌ32.04 B-5.82%
2003-12-31โ‚ฌ34.01 B-0.66%
2002-12-31โ‚ฌ34.24 B-5.03%
2001-12-31โ‚ฌ36.06 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
โ‚ฌ98.20 B 38.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ179.09 B 153.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ111.15 B 57.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ92.05 B 30.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ130.69 B 84.72%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
โ‚ฌ34.19 B-51.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
โ‚ฌ0.81 B-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA